You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
卫生署收到复星医药(02196.HK)提交复必泰接种年龄降至12岁的申请 将考虑专家建议短期内作决定
阿思达克 06-02 10:18
就传媒查询政府降低复必泰疫苗接种年龄下限至12岁的审批进度,食物及卫生局发言人指,卫生署於5月29日收到复星医药(02196.HK)提交有关降低复必泰疫苗接种年龄下限至12岁的申请以及相关的第三期临床研究数据,并已把有关资料提交2019冠状病毒病疫苗顾问专家委员会考虑,邀请委员就有关申请作出建议。

食物及卫生局局长会考虑顾问专家委员会的建议,预计可於短期内就降低接种年龄的申请作出决定。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account